Brussels, 12/01/2012 (Agence Europe) - Françoise Grossetête (EPP, France), who has reacted with great indignation to the scandal of PIP breast implants (see EUROPE 10528), said in a press release on 11 January that she would question the European Commission on the matter. In the context of review of the medical devices directive, which is to take place during the first half of this year, Grossetête decided to raise a question, put directly to the Commission in writing, in order to know whether the Commission plans to review marketing procedures as well as the different forms of a posteriori checks. Pointing out that there is currently no European marketing authorisation (MA) for medical devices, she said that it is time, for the products which present the greatest health risk, to contemplate implementing marketing approval. (IL/transl.jl)